Bigger WuXi Biologics block nets $1.5bn

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Asia

Bigger WuXi Biologics block nets $1.5bn

Jonathan Breen
April 27, 2021 05:45 AM
Pharma_drugs_adobe_575x375.jpg

WuXi Biologics Holdings has raised HK$11.5bn ($1.49bn) after increasing a sale of shares in subsidiary WuXi Biologics (Cayman).

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Health and BiotechEquityChinaHong Kong SARAsiaGreater ChinaMorgan StanleyNortheast AsiaAsia PacificABBs-Block TradesEmerging MarketsSRI
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article